Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine

Polack, Fernando Pedro; Thomas, Stephen J.; Kitchin, Nicholas; Absalon, Judith; Gurtman, Alejandra; Lockhart, Stephen; L. Perez, John; Pérez Marc, Gonzalo; Moreira Junior, Edson Duarte; Zerbini, Cristiano Augusto de Freitas; Bailey, Ruth; Swanson, Kena A.; Roychoudhury, Satrajit; Koury, Kenneth; Ping, Li; Kalina, Warren V.; Cooper, David; Frenck Jr., Robert W.; Hammitt, Laura L.; Türeci, Özlem; Nell, Haylene; Schaefer, Axel; Ünal, Serhat; Tresnan, Dina B.; Mather, Susan; Dormitzer, Philip R.; Sahin, Ugur; Jansen, Kathrin U.; Gruber, William C.

Polack, Fernando Pedro; Thomas, Stephen J.; Kitchin, Nicholas; Absalon, Judith; Gurtman, Alejandra; Lockhart, Stephen; L. Perez, John; Pérez Marc, Gonzalo; Moreira Junior, Edson Duarte; Zerbini, Cristiano Augusto de Freitas; Bailey, Ruth; Swanson, Kena A.; Roychoudhury, Satrajit; Koury, Kenneth; Ping, Li; Kalina, Warren V.; Cooper, David; Frenck Jr., Robert W.; Hammitt, Laura L.; Türeci, Özlem; Nell, Haylene; Schaefer, Axel; Ünal, Serhat; Tresnan, Dina B.; Mather, Susan; Dormitzer, Philip R.; Sahin, Ugur; Jansen, Kathrin U.; Gruber, William C..

Afiliação

Polack, Fernando Pedro; Fundación para la Investigación en Infectología Infantil. Buenos Aires, Argentina..

Article em En | ARCA | ID: arc-46039

Palavras-chave

COVID-19; Vacinas virais; Segurança; Eficácia; SARS-CoV-2; Betacoronavirus; Infecções; Pandemia; COVID-19; Viral vaccine; Safety; Efficacy; SARS-CoV-2; Betacoronavirus; Infection; Pandemic

Texto completo

Imprimir

XML

Buscar no Google